StreetInsider.com News Articles

Form 4 BIO-TECHNE Corp For: Jul 23 Filed by: Bohnen Shane

Mon, 27 Jul 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260727/26819464.html

Form 4 BIO-TECHNE Corp For: Jul 23 Filed by: Bohnen Shane

Mon, 27 Jul 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260727/26819464.html

TD Cowen reports short interest changes in life science stocks

Mon, 27 Jul 2026 12:15:15 -0400

Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.

MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.

Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.

The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.

TD Cowen reports short interest changes in life science stocks

Mon, 27 Jul 2026 12:15:15 -0400

Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.

MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.

Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.

The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.

TD Cowen reports short interest changes in life science stocks

Mon, 27 Jul 2026 12:15:15 -0400

Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.

MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.

Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.

The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.

TD Cowen reports short interest changes in life science stocks

Mon, 27 Jul 2026 12:15:15 -0400

Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.

MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.

Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.

The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.

TD Cowen reports short interest changes in life science stocks

Mon, 27 Jul 2026 12:15:15 -0400

Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.

MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.

Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.

The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.

TD Cowen reports short interest changes in life science stocks

Mon, 27 Jul 2026 12:15:15 -0400

Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.

MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.

Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.

The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.

TD Cowen reports short interest changes in life science stocks

Mon, 27 Jul 2026 12:15:15 -0400

Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.

MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.

Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.

The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.

TD Cowen reports short interest changes in life science stocks

Mon, 27 Jul 2026 12:15:15 -0400

Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.

MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.

Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.

The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.

TD Cowen reports short interest changes in life science stocks

Mon, 27 Jul 2026 12:15:15 -0400

Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.

MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.

Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.

The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.

Form DEFA14A BIO-TECHNE Corp

Thu, 09 Jul 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260709/26753458.html

Form DEFA14A BIO-TECHNE Corp

Thu, 09 Jul 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260709/26753458.html

RBC Capital Downgrades Bio-Techne Corp. (TECH) to Sector Perform

Thu, 09 Jul 2026 02:07:43 -0400

RBC Capital analyst Dan Leonard downgraded Bio-Techne Corp. (NASDAQ: TECH) from Outperform to Sector Perform with a price target of $73.00 (from $62.00).

The analyst comments: “We are downgrading Bio-Tech (TECH) to Sector Perform from Outperform and raising our price target to $73 from $62. The downgrade and price target change reflect our view that Merck KGaA will successfully close its proposed acquisition of Bio-Techne. We believe regulatory risk is minimal, don't see an interloper, and the price is fair by relevant comps.

Bio-Techne checks the boxes as a strategic fit. The protein reagents franchise is best-in-class and history shows demand for

RBC Capital Downgrades Bio-Techne Corp. (TECH) to Sector Perform

Thu, 09 Jul 2026 02:07:43 -0400

RBC Capital analyst Dan Leonard downgraded Bio-Techne Corp. (NASDAQ: TECH) from Outperform to Sector Perform with a price target of $73.00 (from $62.00).

Bio-Techne checks the boxes as a strategic fit. The protein reagents franchise is best-in-class and history shows demand for

Bio-Techne expands AI-engineered protein portfolio for cell therapy

Wed, 08 Jul 2026 06:30:59 -0400

Bio-Techne Corporation (NASDAQ: TECH) announced the launch of five new proteins added to its R&D Systems AI-Engineered Designer Protein portfolio, according to a company press release dated July 8, 2026.

The new additions include FGF-4 Heat Stable, FGF-7 Heat Stable, FGF-8b Heat Stable, IL-3 Heat Stable, and IL-15 Hyperactive. These proteins span the fibroblast growth factor and interleukin cytokine families and are designed for use in cell therapy development, stem cell culture, organoid expansion, and regenerative medicine workflows.

The proteins are engineered using AI-guided design with the goal of improving heat stability, activity, and solubility in cell culture applications. Bio-Techne states the

Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio